出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年11月
Urology Devices Market – Global Forecast to 2028
泌尿器科機器市場 : 製品 (透析、レーザー、砕石術、ロボット、吸入器、ガイドワイヤー、カテーテル、ステント、インプラント)、用途 (腎臓病、がん、骨盤臓器脱、前立腺肥大症、結石)、エンドユーザー、地域別 – 2028年までの世界予測
Urology Devices Market by Product (Dialysis, Laser, Lithotripsy, Robotic, Insufflators, Guidewires, Catheters, Stents, Implants), Application (Kidney Diseases, Cancer, Pelvic Organ Prolapse, BPH, Stones), End User, and Region – Global Forecast to 2028
| ページ数 | 268 |
| 図表数 | 203 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The urology devices market is valued at an estimated USD 34.1 billion in 2023 and is projected to reach USD 48.6 billion by 2028, at a CAGR of 7.3% during the forecast period. Increase in the incidence of chronic diseases like diabetes and blood pressure has led to the increase in prevalence of the urological and kidney conditions which require care and surgical interventions. Urgent and timely treatment is required to manage these patients. The overall increase in the number of minimally invasive procedures is leading to the increased adoption of urology devices in order to ensure the safe and success of the procedures. This is driving the overall growth of the market.
“Consumables & accessories segment accounted for the highest growth rate in the urology devices market, by product, during the forecast period.”
The urology devices market is bifurcated into instruments and consumables & accessories on the basis of product. The instrument segment in the urology devices market is experiencing substantial growth, largely driven by the increasing incidence of diseases such as kidney diseases and cancers. Consumables & accessories segment is also growing due to the rising focus on R&D for the treatment of increasing incidence of chronic diseases.
“kidney diseases segment accounted for the highest growth rate in the urology devices market, by applications, during the forecast period.”
The global urology devices market is bifurcated into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications. The kidney diseases segment is currently witnessing the highest growth rate within the urology devices market. The rising geriatric population and rising incidence of chronic diseases affecting kidneys are the major factors driving this segment’s growth.
“Dialysis centers segment accounted for the highest CAGR.”
Based on end users, the urology devices market is segmented into hospitals, ASCs, and clinics, dialysis centers and home care settings. In 2020, the dialysis centers segment accounted for the highest growth rate. This can be attributed to the increased demand for advanced dialysis products and facilities for ESRD treatment.
“Asia Pacific: The fastest-growing region urology devices market.”
The global urology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the rising geriatric population, increasing prevalence of diabetes, high burden of kidney diseases such as CKD, increasing healthcare spending, growing per capita income, rising demand for cutting-edge technologies, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets are driving the growth of the urology devices market in this region.
The break-up of the profile of primary participants in the urology devices market:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 4%
The key players in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland), Karl Storz (Germany), Cook Medical (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Dialife SA (Switzerland), Erbe Vision (Germany), Well Lead Medical Co., Ltd. (China), ROCAMED (Germany), EndoMed Systems GmbH (Germany), Amniso International, Inc. (US), Medispec (US), Medical Technologies of Georgia (US), Vimex Sp. z o.o. (Poland), Balton Sp. z o.o. (Poland), Hunter Urology (UK), Ribbel International Ltd. (India).
Research Coverage:
This research report categorizes the urology devices market by product (instruments and consumables & accessories), application (kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications), end user (hospitals, ASCS & clinics, dialysis centers and home care settings), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities and challenges, influencing the growth of the urology devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions and services, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urology devices market. Competitive analysis of upcoming startups in the urology devices market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (Rising incidence of urological diseases, growing preference for minimally invasive procedures, rising focus on R&D and product launches, growing number of hospitals and surgical centers), restraints (high degree of consolidation among key players), opportunities (potential growth opportunities in emerging economies, technological advancements) and challenges (increasing number of product recalls by key players, shortage of skilled urologists) influencing the growth of the urology devices market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urology devices market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the urology devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 INCLUSIONS & EXCLUSIONS 29
1.4 MARKET SCOPE 30
1.4.1 MARKETS COVERED 30
1.4.2 REGIONS COVERED 31
1.4.3 YEARS CONSIDERED 31
1.4.4 CURRENCY CONSIDERED 31
1.5 RESEARCH LIMITATIONS 32
1.6 STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 32
1.7.1 RECESSION IMPACT: UROLOGY DEVICES MARKET 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 36
2.1.2.1 Primary sources 36
2.1.2.2 Key data from primary sources 37
2.1.2.3 Key industry insights 38
2.1.2.4 Breakdown of primary interviews 38
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 39
2.2 MARKET SIZE ESTIMATION 39
2.2.1 BOTTOM-UP APPROACH 39
FIGURE 4 COMPANY REVENUE ESTIMATION IN UROLOGY DEVICES MARKET 40
2.2.1.1 Presentations of companies and primary interviews 40
2.2.1.2 Growth forecast 40
2.2.1.3 CAGR projections 41
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
2.2.2 TOP-DOWN APPROACH 41
FIGURE 6 TOP-DOWN APPROACH 42
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 7 DATA TRIANGULATION METHODOLOGY 43
2.4 MARKET SHARE ESTIMATION 44
2.5 STUDY ASSUMPTIONS 44
2.6 GROWTH RATE ASSUMPTIONS 44
2.7 RISK ASSESSMENT 45
TABLE 1 RISK ASSESSMENT: UROLOGY DEVICES MARKET 45
2.8 IMPACT OF ECONOMIC RECESSION ON UROLOGY DEVICES MARKET 45
3 EXECUTIVE SUMMARY 47
FIGURE 8 UROLOGY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 47
FIGURE 9 UROLOGY DEVICES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 48
FIGURE 10 UROLOGY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 48
FIGURE 11 UROLOGY DEVICES MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 49
4 PREMIUM INSIGHTS 50
4.1 UROLOGY DEVICES MARKET OVERVIEW 50
FIGURE 12 RISING PREVALENCE OF UROLOGICAL DISEASES TO DRIVE MARKET 50
4.2 UROLOGY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 51
FIGURE 13 INSTRUMENTS TO DOMINATE UROLOGY DEVICES MARKET DURING FORECAST PERIOD 51
4.3 UROLOGY DEVICES MARKET, BY APPLICATION, 2023 VS. 2028 51
FIGURE 14 KIDNEY DISEASES TO COMMAND LARGEST MARKET SHARE IN 2028 51
4.4 UROLOGY DEVICES MARKET, BY END USER, 2023 VS. 2028 52
FIGURE 15 HOSPITALS, ASCS, AND CLINICS SEGMENT TO DOMINATE MARKET DURING STUDY PERIOD 52
4.5 REGIONAL GROWTH OPPORTUNITIES: UROLOGY DEVICES MARKET 52
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: UROLOGY DEVICES MARKET 53
5.2.1 DRIVERS 54
5.2.1.1 Rising incidence of urological diseases 54
TABLE 2 GLOBAL INCIDENCE OF UROLOGICAL CANCER, 2020 54
TABLE 3 ESTIMATED NEW UROLOGICAL CANCER CASES AND DEATHS IN US, 2022 55
5.2.1.2 Growing preference for minimally invasive procedures 55
TABLE 4 ESTIMATED MARKET SIZE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES, 2021–2030 56
5.2.1.3 Rising focus on R&D and product launches 56
5.2.1.4 Growing number of hospitals and surgical centers 57
5.2.2 RESTRAINTS 57
5.2.2.1 High degree of consolidation among key players 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Potential growth opportunities in emerging economies 58
5.2.3.2 Technological advancements 58
5.2.4 CHALLENGES 59
5.2.4.1 Increasing number of product recalls by key players 59
TABLE 5 LIST OF PRODUCT RECALLS BY KEY PLAYERS, 2021–2023 60
5.2.4.2 Shortage of skilled urologists 60
5.3 PRICING ANALYSIS 61
TABLE 6 INDICATIVE PRICING FOR UROLOGY DEVICES (IN USD) 61
5.3.1 AVERAGE SELLING PRICE OF UROLOGY DEVICES 61
TABLE 7 AVERAGE SELLING PRICE OF UROLOGY DEVICES, BY REGION 61
5.4 VALUE CHAIN ANALYSIS 62
FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 62
5.5 SUPPLY CHAIN ANALYSIS 63
FIGURE 19 SUPPLY CHAIN ANALYSIS 63
5.6 PATENT ANALYSIS 64
FIGURE 20 PATENT ANALYSIS FOR UROLOGY DEVICES, JANUARY 2013–DECEMBER 2022 64
TABLE 8 LIST OF MAJOR PATENTS, 2020–2022 65
5.7 TRADE ANALYSIS 66
5.7.1 TRADE ANALYSIS FOR UROLOGY DEVICES 66
TABLE 9 IMPORT DATA FOR DIALYSIS INSTRUMENTS, BY COUNTRY, 2018–2022 (USD MILLION) 66
TABLE 10 EXPORT DATA FOR DIALYSIS INSTRUMENTS, BY COUNTRY, 2018–2022 (USD MILLION) 67
5.8 ECOSYSTEM MARKET/MAP 67
FIGURE 21 ECOSYSTEM MARKET MAP 67
TABLE 11 ROLE IN ECOSYSTEM 68
5.9 PORTER’S FIVE FORCES ANALYSIS 68
TABLE 12 PORTER’S FIVE FORCES 68
5.9.1 THREAT OF NEW ENTRANTS 69
5.9.2 THREAT OF SUBSTITUTES 69
5.9.3 BARGAINING POWER OF SUPPLIERS 69
5.9.4 BARGAINING POWER OF BUYERS 69
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.10 PESTLE ANALYSIS 70
5.11 REGULATORY ANALYSIS 71
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
5.11.1 NORTH AMERICA 72
5.11.1.1 US 72
5.11.1.2 Canada 73
5.11.2 EUROPE 73
5.11.3 ASIA PACIFIC 73
5.11.3.1 China 73
5.11.3.2 Japan 73
5.11.3.3 India 73
5.11.4 LATIN AMERICA 73
5.11.4.1 Brazil 74
5.11.4.2 Mexico 74
5.11.5 MIDDLE EAST 74
5.11.6 AFRICA 75
5.12 KEY CONFERENCES & EVENTS 75
TABLE 17 DETAILED LIST OF KEY CONFERENCES & EVENTS IN 2023–2024 75
5.13 TECHNOLOGY ANALYSIS 77
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78
FIGURE 22 REVENUE SHIFT IN UROLOGY DEVICES MARKET 78
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 78
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 78
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR UROLOGY DEVICES 78
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR UROLOGY DEVICES (%) 79
5.15.2 BUYING CRITERIA 79
FIGURE 24 KEY BUYING CRITERIA FOR END USERS OF UROLOGY DEVICES 79
TABLE 19 KEY BUYING CRITERIA, BY END USER 79
5.16 CASE STUDY ANALYSIS 80
5.16.1 CASE STUDY: IDENTIFICATION OF FACTORS FOR SURGICAL ADVANCEMENTS 80
6 UROLOGY DEVICES MARKET, BY PRODUCT 81
6.1 INTRODUCTION 82
TABLE 20 UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 82
6.1.1 PRIMARY NOTES 82
6.1.1.1 Key industry insights 82
6.2 INSTRUMENTS 82
TABLE 21 UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 22 UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 83
6.2.1 DIALYSIS DEVICES 84
TABLE 23 DIALYSIS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 24 DIALYSIS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 85
6.2.1.1 Hemodialysis devices 85
6.2.1.1.1 Technological advancements and increased need for home dialysis to drive segment 85
TABLE 25 HEMODIALYSIS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 86
6.2.1.2 Peritoneal dialysis devices 86
6.2.1.2.1 Cost-effectiveness and lesser time consumption to drive segment 86
TABLE 26 PERITONEAL DIALYSIS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 87
6.2.2 ENDOSCOPES 87
TABLE 27 ENDOSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 28 ENDOSCOPES MARKET, BY TYPE, 2021–2028 (USD MILLION) 88
6.2.2.1 Laparoscopes 89
6.2.2.1.1 Reduced chances of surgical-site infection and faster recovery rates to drive segment 89
TABLE 29 LAPAROSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
6.2.2.2 Ureteroscopes 90
6.2.2.2.1 Technological advancements and development of advanced ureteroscopy for kidney stones to drive segment 90
TABLE 30 URETEROSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION) 91
6.2.2.3 Nephroscopes 91
6.2.2.3.1 Increasing incidence of chronic kidney diseases to drive segment 91
TABLE 31 NEPHROSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION) 92
6.2.2.4 Resectoscopes 92
6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to drive segment 92
TABLE 32 RESECTOSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION) 93
6.2.2.5 Cystoscopes 93
6.2.2.5.1 Increasing prevalence of urological cancers to drive segment 93
TABLE 33 CYSTOSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION) 94
6.2.3 LASER & LITHOTRIPSY DEVICES 94
6.2.3.1 Increasing prevalence of kidney stones to drive segment 94
TABLE 34 LASER & LITHOTRIPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
6.2.4 ENDOVISION & IMAGING SYSTEMS 95
6.2.4.1 Need for high-resolution images for better observation of body cavities and organs to drive segment 95
TABLE 35 ENDOVISION & IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 97
6.2.5 ROBOTIC SYSTEMS 97
6.2.5.1 Increasing public-private collaborations for research on minimally invasive surgeries to drive segment 97
TABLE 36 ROBOTIC SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 98
6.2.6 INSUFFLATORS 98
6.2.6.1 Increasing number of laparoscopic surgeries to drive segment 98
TABLE 37 INSUFFLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 99
6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS 99
6.2.7.1 Ease of use, improved safety, and reduced medical expense to drive segment 99
TABLE 38 ENDOSCOPY FLUID MANAGEMENT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 100
6.2.8 URODYNAMIC SYSTEMS 100
6.2.8.1 Growing patient pool in emerging economies to drive segment 100
TABLE 39 URODYNAMIC SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 101
6.2.9 OTHER INSTRUMENTS 101
TABLE 40 OTHER INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 102
6.3 CONSUMABLES & ACCESSORIES 102
TABLE 41 UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 42 UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 103
6.3.1 DIALYSIS CONSUMABLES 103
6.3.1.1 Increasing use of dialyzers and rising number of repeat purchases to drive segment 103
TABLE 43 DIALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 104
6.3.2 CATHETERS 104
6.3.2.1 High prevalence of urinary incontinence and increased number of surgical procedures to drive segment 104
TABLE 44 CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 105
6.3.3 GUIDEWIRES 105
6.3.3.1 Development of next-generation hybrid guidewires and increased applications in endoscopy to drive segment 105
TABLE 45 GUIDEWIRES MARKET, BY REGION, 2021–2028 (USD MILLION) 106
6.3.4 RETRIEVAL DEVICES & EXTRACTORS 106
6.3.4.1 Growing number of kidney stone removal surgeries to drive market 106
TABLE 46 RETRIEVAL DEVICES & EXTRACTORS MARKET, BY REGION, 2021–2028 (USD MILLION) 107
6.3.5 SURGICAL DISSECTORS, FORCEPS, AND NEEDLE HOLDERS 107
6.3.5.1 Growing number of urology procedures and increasing prevalence of chronic kidney diseases to drive segment 107
TABLE 47 SURGICAL DISSECTORS, FORCEPS, AND NEEDLE HOLDERS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS 108
6.3.6.1 Growing demand for effective endoscopic management of ureteral and renal calculi to drive segment 108
TABLE 48 DILATOR SETS & URETHRAL ACCESS SHEATHS MARKET, BY REGION, 2021–2028 (USD MILLION) 109
6.3.7 STENTS & IMPLANTS 109
6.3.7.1 Growing prevalence of kidney-related disorders and erectile dysfunction to drive segment 109
TABLE 49 STENTS & IMPLANTS MARKET, BY REGION, 2021–2028 (USD MILLION 110
6.3.8 BIOPSY DEVICES 110
6.3.8.1 High incidence of prostate cancer among male geriatric population to drive segment 110
TABLE 50 BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 111
6.3.9 TUBES & DISTAL ATTACHMENTS 111
6.3.9.1 Growing demand for endoscopy and colonoscopy procedures to drive market 111
TABLE 51 TUBES & DISTAL ATTACHMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 112
6.3.10 DRAINAGE BAGS 112
6.3.10.1 Increased risk of urinary tract infections to limit market 112
TABLE 52 DRAINAGE BAGS MARKET, BY REGION, 2021–2028 (USD MILLION) 113
6.3.11 OTHER CONSUMABLES & ACCESSORIES 113
TABLE 53 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 114
7 UROLOGY DEVICES MARKET, BY APPLICATION 115
7.1 INTRODUCTION 116
TABLE 54 UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
7.2 KIDNEY DISEASES 116
7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO DRIVE MARKET 116
TABLE 55 UROLOGY DEVICES MARKET FOR KIDNEY DISEASES, BY REGION, 2021–2028 (USD MILLION) 117
7.3 UROLOGICAL CANCER 118
7.3.1 RISING PREVALENCE OF SURGERIES FOR UROLOGICAL CANCER TREATMENT TO DRIVE MARKET 118
TABLE 56 UROLOGY DEVICES MARKET FOR UROLOGICAL CANCER, BY REGION, 2021–2028 (USD MILLION) 118
7.4 PELVIC ORGAN PROLAPSE 119
7.4.1 HIGH COST OF SURGERIES AND LACK OF EFFECTIVE PELVIC ORGAN PROLAPSE TREATMENT TO LIMIT MARKET 119
TABLE 57 UROLOGY DEVICES MARKET FOR PELVIC ORGAN PROLAPSE, BY REGION, 2021–2028 (USD MILLION) 119
7.5 BENIGN PROSTATIC HYPERPLASIA 120
7.5.1 GROWING GERIATRIC POPULATION AND IMPROVING TREATMENT OPTIONS TO DRIVE MARKET 120
TABLE 58 UROLOGY DEVICES MARKET FOR BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2021–2028 (USD MILLION) 120
7.6 URINARY INCONTINENCE 121
7.6.1 GROWING PREVALENCE OF URINARY INCONTINENCE IN OLDER POPULATION TO DRIVE MARKET 121
TABLE 59 ESTIMATED PREVALENCE FOR TYPES OF URINARY INCONTINENCE, 2022 121
TABLE 60 UROLOGY DEVICES MARKET FOR BENIGN URINARY INCONTINENCE, BY REGION, 2021–2028 (USD MILLION) 122
7.7 ERECTILE DYSFUNCTION 122
7.7.1 RISING PREVALENCE OF PROSTATE CANCER TO DRIVE MARKET 122
TABLE 61 UROLOGY DEVICES MARKET FOR ERECTILE DYSFUNCTION, BY REGION, 2021–2028 (USD MILLION) 123
7.8 URINARY STONES 123
7.8.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET 123
TABLE 62 UROLOGY DEVICES MARKET FOR URINARY STONES, BY REGION, 2021–2028 (USD MILLION) 124
7.9 OTHER APPLICATIONS 124
TABLE 63 UROLOGY DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 125
8 UROLOGY DEVICES MARKET, BY END USER 126
8.1 INTRODUCTION 127
TABLE 64 UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 127
8.2 HOSPITALS, ASCS, AND CLINICS 127
8.2.1 HOSPITALS, ASCS, AND CLINICS SEGMENT TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD 127
TABLE 65 UROLOGY DEVICES MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021–2028 (USD MILLION) 129
8.3 DIALYSIS CENTERS 129
8.3.1 INCREASED DEMAND FOR ADVANCED DIALYSIS PRODUCTS AND FACILITIES TO DRIVE MARKET 129
TABLE 66 NUMBER OF DIALYSIS CENTERS IN US, BY COMPANY, 2022 130
TABLE 67 UROLOGY DEVICES MARKET FOR DIALYSIS CENTERS, BY REGION, 2021–2028 (USD MILLION) 130
8.4 HOME CARE SETTINGS 130
8.4.1 UNAVAILABILITY OF DIALYSIS CENTERS IN EMERGING ECONOMIES TO DRIVE MARKET 130
TABLE 68 UROLOGY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2021–2028 (USD MILLION) 131
9 UROLOGY DEVICES MARKET, BY REGION 132
9.1 INTRODUCTION 133
TABLE 69 UROLOGY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 133
9.2 NORTH AMERICA 133
FIGURE 25 NORTH AMERICA: UROLOGY DEVICES MARKET SNAPSHOT 134
TABLE 70 NORTH AMERICA: UROLOGY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 71 NORTH AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 135
TABLE 72 NORTH AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136
TABLE 73 NORTH AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 136
9.2.1 NORTH AMERICA: RECESSION IMPACT 137
9.2.2 US 137
9.2.2.1 US to dominate North American urology devices market during forecast period 137
TABLE 74 US: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 138
TABLE 75 US: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 76 US: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 77 US: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 140
9.2.3 CANADA 140
9.2.3.1 Rising prevalence of urological cancers and diabetes to drive market 140
TABLE 78 CANADA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 141
TABLE 79 CANADA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 80 CANADA: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 81 CANADA: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 142
9.3 EUROPE 143
TABLE 82 EUROPE: UROLOGY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 83 EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 144
TABLE 84 EUROPE: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
TABLE 85 EUROPE: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 145
9.3.1 EUROPE: RECESSION IMPACT 145
9.3.2 GERMANY 145
9.3.2.1 Rising geriatric population and growing incidence of urological cancers to drive market 145
TABLE 86 GERMANY: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 146
TABLE 87 GERMANY: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 88 GERMANY: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147
TABLE 89 GERMANY: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 148
9.3.3 UK 148
9.3.3.1 Rising incidence of kidney diseases and better reimbursement policies for dialysis to drive market 148
TABLE 90 UK: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 91 UK: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 92 UK: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 93 UK: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 150
9.3.4 FRANCE 150
9.3.4.1 Favorable government initiatives and rising number of surgical procedures to drive market 150
TABLE 94 FRANCE: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 95 FRANCE: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 96 FRANCE: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 97 FRANCE: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 153
9.3.5 ITALY 153
9.3.5.1 Increasing cases of chronic kidney diseases and rising geriatric population to drive market 153
TABLE 98 ITALY: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 154
TABLE 99 ITALY: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 100 ITALY: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 101 ITALY: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 155
9.3.6 SPAIN 155
9.3.6.1 Increasing government initiatives and healthcare funding to drive market 155
TABLE 102 SPAIN: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 156
TABLE 103 SPAIN: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 104 SPAIN: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 105 SPAIN: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 158
9.3.7 REST OF EUROPE 158
TABLE 106 REST OF EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 107 REST OF EUROPE: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 108 REST OF EUROPE: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 160
TABLE 109 REST OF EUROPE: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 160
9.4 ASIA PACIFIC 161
FIGURE 26 ASIA PACIFIC: UROLOGY DEVICES MARKET SNAPSHOT 162
TABLE 110 ASIA PACIFIC: UROLOGY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 111 ASIA PACIFIC: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 163
TABLE 112 ASIA PACIFIC: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 164
TABLE 113 ASIA PACIFIC: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 164
9.4.1 ASIA PACIFIC: RECESSION IMPACT 164
9.4.2 CHINA 165
9.4.2.1 Improving healthcare infrastructure and rising disposable income of middle-class population to drive market 165
TABLE 114 CHINA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 165
TABLE 115 CHINA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 116 CHINA: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 117 CHINA: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 167
9.4.3 JAPAN 167
9.4.3.1 Well-established healthcare system and large geriatric population to drive market 167
TABLE 118 JAPAN: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 168
TABLE 119 JAPAN: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 120 JAPAN: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 169
TABLE 121 JAPAN: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 169
9.4.4 INDIA 170
9.4.4.1 Improvement in healthcare infrastructure and presence of large patient pool to drive market 170
TABLE 122 INDIA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
TABLE 123 INDIA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 124 INDIA: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 172
TABLE 125 INDIA: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 172
9.4.5 REST OF ASIA PACIFIC 172
TABLE 126 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 173
TABLE 127 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 128 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174
TABLE 129 REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 175
9.5 LATIN AMERICA 175
9.5.1 RISING PREVALENCE OF CHRONIC DISEASES AND GROWING PATIENT POOL TO DRIVE MARKET 175
TABLE 130 LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 176
TABLE 131 LATIN AMERICA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 132 LATIN AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 133 LATIN AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 177
9.5.2 LATIN AMERICA: RECESSION IMPACT 177
9.6 MIDDLE EAST & AFRICA 178
9.6.1 INCREASING HEALTHCARE EXPENDITURE AND IMPROVING HEALTHCARE SYSTEM TO DRIVE MARKET 178
TABLE 134 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 178
TABLE 135 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 136 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 137 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 180
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 180
10 COMPETITIVE LANDSCAPE 181
10.1 OVERVIEW 181
10.2 KEY STRATEGIES/RIGHT TO WIN 181
TABLE 138 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN UROLOGY DEVICES MARKET 182
10.3 REVENUE SHARE ANALYSIS 183
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS 183
10.4 MARKET SHARE ANALYSIS 184
FIGURE 28 UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2022 184
TABLE 139 DEGREE OF COMPETITION: UROLOGY DEVICES MARKET 185
10.5 COMPANY EVALUATION MATRIX 186
10.5.1 STARS 186
10.5.2 EMERGING LEADERS 186
10.5.3 PERVASIVE PLAYERS 186
10.5.4 PARTICIPANTS 186
FIGURE 29 COMPANY EVALUATION MATRIX, 2022 187
10.5.5 COMPANY FOOTPRINT 187
FIGURE 30 PRODUCT AND REGIONAL FOOTPRINT 187
TABLE 140 PRODUCT FOOTPRINT 188
TABLE 141 REGIONAL FOOTPRINT 188
10.6 SME/START-UP EVALUATION MATRIX 189
10.6.1 PROGRESSIVE COMPANIES 189
10.6.2 RESPONSIVE COMPANIES 189
10.6.3 DYNAMIC COMPANIES 189
10.6.4 STARTING BLOCKS 189
FIGURE 31 START-UP/SME EVALUATION MATRIX, 2022 190
10.6.5 COMPETITIVE BENCHMARKING 190
TABLE 142 COMPETITIVE BENCHMARKING OF KEY PLAYERS 190
TABLE 143 DETAILED LIST OF KEY START-UPS/SMES 191
10.7 COMPETITIVE SCENARIOS AND TRENDS 191
10.7.1 KEY PRODUCT LAUNCHES & APPROVALS 191
TABLE 144 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–OCTOBER 2023 191
10.7.2 KEY DEALS 193
TABLE 145 KEY DEALS, JANUARY 2020–OCTOBER 2023 193
10.7.3 OTHER KEY DEVELOPMENTS 194
TABLE 146 OTHER KEY DEVELOPMENTS, JANUARY 2020–OCTOBER 2023 194
11 COMPANY PROFILES 195
(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1 KEY PLAYERS 195
11.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA 195
TABLE 147 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY OVERVIEW 195
FIGURE 32 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2022) 196
11.1.2 BAXTER INTERNATIONAL, INC. 199
TABLE 148 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW 199
FIGURE 33 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022) 200
11.1.3 BOSTON SCIENTIFIC CORPORATION 203
TABLE 149 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 203
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 204
11.1.4 BECTON, DICKINSON AND COMPANY 208
TABLE 150 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 208
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 209
11.1.5 B. BRAUN MELSUNGEN AG 215
TABLE 151 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 215
FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) 216
11.1.6 CARDINAL HEALTH 220
TABLE 152 CARDINAL HEALTH: COMPANY OVERVIEW 220
FIGURE 37 CARDINAL HEALTH: COMPANY SNAPSHOT (2022) 221
11.1.7 OLYMPUS CORPORATION 223
TABLE 153 OLYMPUS CORPORATION: COMPANY OVERVIEW 223
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022) 224
11.1.8 INTUITIVE SURGICAL 228
TABLE 154 INTUITIVE SURGICAL: COMPANY OVERVIEW 228
FIGURE 39 INTUITIVE SURGICAL: COMPANY SNAPSHOT (2022) 229
11.1.9 COLOPLAST A/S 230
TABLE 155 COLOPLAST A/S: COMPANY OVERVIEW 230
FIGURE 40 COLOPLAST A/S: COMPANY SNAPSHOT (2022) 231
11.1.10 STRYKER CORPORATION 233
TABLE 156 STRYKER CORPORATION: COMPANY OVERVIEW 233
FIGURE 41 STRYKER CORPORATION: COMPANY SNAPSHOT (2022) 234
11.1.11 TELEFLEX INCORPORATED 236
TABLE 157 TELEFLEX INCORPORATED: COMPANY OVERVIEW 236
FIGURE 42 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022) 237
11.1.12 CONVATEC GROUP PLC 242
TABLE 158 CONVATEC GROUP PLC: COMPANY OVERVIEW 242
FIGURE 43 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2022) 243
11.1.13 MEDTRONIC PLC 245
TABLE 159 MEDTRONIC PLC: COMPANY OVERVIEW 245
FIGURE 44 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 246
11.2 OTHER PLAYERS 248
11.2.1 KARL STORZ 248
11.2.2 COOK MEDICAL 249
11.2.3 RICHARD WOLF GMBH 252
11.2.4 COMPACTCATH 253
11.2.5 DORNIER MEDTECH 254
11.2.6 NIKKISO CO., LTD. 255
11.2.7 DIALIFE SA 256
11.2.8 ERBE VISION 257
11.2.9 WELL LEAD MEDICAL CO., LTD. 257
11.2.10 ROCAMED 259
11.2.11 ENDOMED SYSTEMS GMBH 260
11.2.12 AMSINO INTERNATIONAL, INC. 261
11.2.13 MEDISPEC 262
11.2.14 MEDICAL TECHNOLOGIES OF GEORGIA 263
11.2.15 VIMEX SP. Z O. O. 264
11.2.16 BALTON SP. Z O.O. 265
11.2.17 HUNTER UROLOGY (PART OF OPTIMUM MEDICAL GROUP) 266
11.2.18 RIBBEL INTERNATIONAL LIMITED 267
*Details on Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 268
12.1 DISCUSSION GUIDE 268
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 271
12.3 CUSTOMIZATION OPTIONS 273
12.4 RELATED REPORTS 273
12.5 AUTHOR DETAILS 274